These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 38542332)
41. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications. Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561 [TBL] [Abstract][Full Text] [Related]
42. Advances in prognostic markers for colorectal cancer Duan L; Yang W; Wang X; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D Expert Rev Mol Diagn; 2019 Apr; 19(4):313-324. PubMed ID: 30907673 [TBL] [Abstract][Full Text] [Related]
43. Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review. Ghadiri Moghaddam F; Farajnia S; Karbalaei-Mahdi M; Monir L Mol Biol Rep; 2022 Oct; 49(10):10013-10022. PubMed ID: 35727475 [TBL] [Abstract][Full Text] [Related]
45. Colorectal cancer microenvironment: among nutrition, gut microbiota, inflammation and epigenetics. Garagnani P; Pirazzini C; Franceschi C Curr Pharm Des; 2013; 19(4):765-78. PubMed ID: 23016865 [TBL] [Abstract][Full Text] [Related]
46. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of epigenetic methylation biomarkers for the detection of colorectal cancer using droplet digital PCR. Petit J; Carroll G; Zhao J; Roper E; Pockney P; Scott RJ Sci Rep; 2023 Jun; 13(1):8883. PubMed ID: 37264006 [TBL] [Abstract][Full Text] [Related]
48. Epigenetic Alteration in Colorectal Cancer: A Biomarker for Diagnostic and Therapeutic Application. Essa HYS; Kusaf G; Yuruker O; Kalkan R Glob Med Genet; 2022 Sep; 9(3):258-262. PubMed ID: 36188672 [TBL] [Abstract][Full Text] [Related]
49. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression. Muthamilselvan S; Raghavendran A; Palaniappan A PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405 [TBL] [Abstract][Full Text] [Related]
50. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer. Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011 [TBL] [Abstract][Full Text] [Related]
51. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834 [TBL] [Abstract][Full Text] [Related]
52. Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration. Oh CK; Cho YS Intest Res; 2024 Apr; 22(2):131-151. PubMed ID: 38295766 [TBL] [Abstract][Full Text] [Related]
53. Ansar M; Wang CJ; Wang YH; Shen TH; Hung CS; Chang SC; Lin RK Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036415 [TBL] [Abstract][Full Text] [Related]
54. Genetic and epigenetic markers in colorectal cancer screening: recent advances. Singh MP; Rai S; Suyal S; Singh SK; Singh NK; Agarwal A; Srivastava S Expert Rev Mol Diagn; 2017 Jul; 17(7):665-685. PubMed ID: 28562109 [TBL] [Abstract][Full Text] [Related]
55. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications. Yang Y; Yan X; Li X; Ma Y; Goel A Cancer Lett; 2021 Apr; 504():67-80. PubMed ID: 33577977 [TBL] [Abstract][Full Text] [Related]
57. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications. Kasprzak A; Adamek A Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387 [TBL] [Abstract][Full Text] [Related]
58. Comprehensive analysis of epigenetic pattern of long noncoding RNA loci in colorectal cancer. Liao Q; Chen L; Liu J; Yang T; Li J; Zhang X; Zhao J Gene; 2016 Dec; 595(1):9-17. PubMed ID: 27642123 [TBL] [Abstract][Full Text] [Related]
59. The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma. Wang B; Fan W; Tao Y; Zhang S; Wang J; Fan Z; Liu L; Wang Y Eur J Med Res; 2024 Jan; 29(1):20. PubMed ID: 38178258 [TBL] [Abstract][Full Text] [Related]
60. DNA methylation markers in colorectal cancer. Kim MS; Lee J; Sidransky D Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]